Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Application Deadline 11 Nov 2025 - 05:55 (Europe/Berlin) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Other EU programme Is the Job related to
-
the necessary interface between the computer and the neural network of the human retina in vivo – without introducing additional modifications to our organisms. Such an interface could, in turn, be developed
-
cutting edge technologies incorporating techniques such as in vivo Ca2+ imaging, electrophysiology, bioengineering, brain computer/machine interfaces, neuromodulation and/or computational approaches
-
The Laboratories for Gut-Immune-Brain Axis Research (GIBA, Prof. Seppe De Schepper) and the Microglia and Inflammation in Neurological Disorders lab (MIND, Prof. Renzo Mancuso) at the VIB–Center
-
to engineer new rehabilitation therapies and technologies. (See https://www.rnel.pitt.edu/). RNEL is a world leader in clinical neural interface research, having made headlines in recent years for work in brain
-
Brain Interfaces’. The NeuroNanotech project aims to develop next-generation neurotechnological tools by integrating computational and experimental approaches to understand how nanoscale materials and
-
neuroengineers.•promote the valorisation of research, including potential applications in neurotechnology, brain-computer interfaces and neurological disease models, in collaboration with academic, clinical and
-
on flexible microsystems that can be implanted in the body, for example as part of nerve-controlled bionic limbs or for direct coupling to signals in the brain. We develop nano- and microfabrication methods
-
critical illness insurance, giving you peace of mind and the support you need to thrive in all aspects of your life. Future and current OSU employees can use the Benefits Calculator to learn more about the
-
------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------...